| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |